Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · IEX Real-Time Price · USD
21.50
+0.51 (2.43%)
At close: Apr 26, 2024, 4:00 PM
20.57
-0.93 (-4.33%)
After-hours: Apr 26, 2024, 7:38 PM EDT
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $630.96 million as of April 26, 2024. Its market cap has increased by 1,265.71% in one year.
Market Cap
630.96M
Enterprise Value
457.82M
1-Year Change
1,265.71%
Ranking
Category
Stock Price
$21.50
Market Cap Chart
Since June 21, 2018, Dianthus Therapeutics's market cap has increased from $499.10M to $630.96M, an increase of 26.42%. That is a compound annual growth rate of 4.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 26, 2024 | 631.00M | 2.44% |
| Apr 25, 2024 | 616.00M | -1.55% |
| Apr 24, 2024 | 625.70M | -8.96% |
| Apr 23, 2024 | 687.30M | 0.78% |
| Apr 22, 2024 | 682.00M | -0.04% |
| Apr 19, 2024 | 682.30M | -1.62% |
| Apr 18, 2024 | 693.50M | 1.24% |
| Apr 17, 2024 | 685.00M | -3.30% |
| Apr 16, 2024 | 708.40M | -4.48% |
| Apr 15, 2024 | 741.60M | -2.40% |
| Apr 12, 2024 | 759.80M | 3.98% |
| Apr 11, 2024 | 730.70M | 9.11% |
| Apr 10, 2024 | 669.70M | -5.38% |
| Apr 9, 2024 | 707.80M | 2.28% |
| Apr 8, 2024 | 692.00M | -6.02% |
| Apr 5, 2024 | 736.30M | 1.46% |
| Apr 4, 2024 | 725.70M | -5.73% |
| Apr 3, 2024 | 769.80M | -1.72% |
| Apr 2, 2024 | 783.30M | -10.19% |
| Apr 1, 2024 | 872.20M | -0.93% |
| Mar 28, 2024 | 880.40M | -1.96% |
| Mar 27, 2024 | 898.00M | -2.92% |
| Mar 26, 2024 | 925.00M | 1.70% |
| Mar 25, 2024 | 909.50M | -2.97% |
| Mar 22, 2024 | 937.30M | 14.32% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Disc Medicine | 673.79M |
| Y-mAbs Therapeutics | 669.35M |
| Treace Medical Concepts | 658.93M |
| enGene Holdings | 650.49M |
| Embecta | 627.03M |
| HilleVax | 625.24M |
| Cabaletta Bio | 625.21M |
| ProKidney | 623.08M |